Efficacy and Safety of Long-Term Eltrombopag Treatment in Patients with Chronic Immune Thrombocytopenia: A Single Center Study.
Phase of Trial: Phase IV
Latest Information Update: 06 Sep 2016
At a glance
- Drugs Eltrombopag (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 06 Sep 2016 New trial record